アスリートとGPL1受容体薬

(8) https://www.acpjournals.org/doi/10.7326/M24-0019

(9) https://investor.lilly.com/news-releases/news-release-details/open-letter-regarding-use-mounjaror-tirzepatide-and-zepboundr

(10) https://nabp.pharmacy/wp-content/uploads/2024/04/RogueRx-Activity-Report-Injectable-Weight-Loss-Drugs-2024.pdf

(11) https://www.reuters.com/business/healthcare-pharmaceuticals/more-than-250-websites-selling-fake-weight-loss-drugs-reported-by-anti-2024-04-15/

(12) https://jamanetwork.com/journals/jama/article-abstract/2821502

(13) https://www.nytimes.com/2024/07/12/well/ozempic-fake-counterfeit-drugs.html

トップ写真：パリ五輪のオープンセレモニーに参加するリリアン・テュラム氏とカール・ルイス氏　出典：Photo by Karwai Tang/WireImage

この記事は、MRIC by 医療ガバナンス学会「 Vol.24158 アスリートとGLP１受容体薬」の転載です。